MPO and psoriasis: Myeloperoxidase, protein carbonyl compounds, advanced oxidation protein products, lipid hydroperoxides and pyrrolized proteins, although they are significantly increased in patients with psoriasis, regardless of PASI, and do not correlate with the severity of the disease, there are no significant differences between groups of patients with mild, moderate or severe forms [34].